Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Solas Capital Management, LLC reported a 7.20% stake in Fennec Pharmaceuticals Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Solas Capital Management, LLC reported a 7.20% stake in Fennec Pharmaceuticals Inc., 2,482,198 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
7.20%
Shares
2,482,198
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Solas Capital Management, LLC7.20%2,482,198
FREDERICK TUCKER GOLDEN7.20%2,482,198

Source

View original at SEC

Related